240
Participants
Start Date
December 31, 2011
Primary Completion Date
October 31, 2017
Study Completion Date
October 31, 2017
rFVIIIFc
Administered as specified in the treatment arm.
Research Site, Auckland
Research Site, Vienna
Research Site, Brussels
Research Site, Camperdown
Research Site, Johannesburg
Research Site, Melbourne
Research site, Melbourne
Research site, Hamilton
Research Site, South Brisbane
Research Site, Palmerston North
Research Site, Adelaide
Research Site, Subiaco
Research site, Wellington
Research Site, Murdoch
Research Site, Cape Town
Research Site, Christchurch
Research Site, Barcelona
Research Site, Zurich
Research Site, Berlin
Research Site, Pittsburgh
Research Site, Philadelphia
Research Site, Philadelphia
Research Site, Washington D.C.
Research Site, Milan
Research Site, Chapel Hill
Research Site, Madrid
Research Site, Vicenza
Research Site, Gothenburg
Research Site, Cincinnati
Research Site, Indianapolis
Research Site, East Lansing
Research Site, Florence
Research Site, Iowa City
Research Site, Ramat Gan
Research Site, Bonn
Research Site, St Louis
Research Site, Bron
Research Site, New Orleans
Research Site, Houston
Research Site, Salt Lake City
Research Site, Las Vegas
Research Site, Los Angeles
Research Site, Los Angeles
Research Site, San Diego
Research Site, Orange
Research Site, Sacramento
Research Site, Portland
Research Site, Seattle
Research Site, New Delhi
Research Site, Ludhiana
Research Site, Pune
Research Site, Bangalore
Research Site, Vellore
Research Site, Boston
Research Site, Campinas
Research Site, Vancouver
Research Site, Toronto
Children Cancer Centre, Hong Kong
Sir Yue Kong Pao Center for Cancer, Hong Kong
Research Site, Hong Kong
Research Site, Dublin
Research Site, Nagoya
Research Site, Kitakyushu
Research Site, Kawasaki
Research Site, Kashihara-shi
Research Site, Shinjuku-ku
Research Site, Tokyo
Research Site, Groningen
Research Site, Lublin
Research Site, Cambridge
Research Site, London
Research Site, London
Research Site, London
Research Site, London
Research Site, Basingstoke
Research Site, Hamstead
Research Site, Glasgow
Research Site, Glasgow
Lead Sponsor
Bioverativ Therapeutics Inc.
INDUSTRY